The independent source for health policy research, polling, and news.
621 - 640 of 1,380 Results
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
More than 95% of the Arkansas residents targeted by the state’s Medicaid work requirement were already working or met the criteria to be exempted from the mandate, according to a study in the New England Journal of Medicine.
Justices won’t alter the rule that prevents active-duty military members from suing the government for negligence. The challenge came from the family of Navy nurse Lt. Rebekah “Moani” Daniel, who died in 2014 after bleeding to death following childbirth.
The loss of the longtime hospital in Fort Scott, Kan., forces trauma patients to deal with changing services and expectations.
It’s never easy to tell a patient about a terminal illness, but a longtime doctor whose own diagnosis was botched says physicians must do better.
As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.
As people advance in age, the expectations for what constitutes good health change. People focus on positive emotions and satisfaction with life, while physical ailments play a less important role.
Crowded emergency rooms are likely to blame. In 2017, the median ER wait time for patients before admission as inpatients to California hospitals was 336 minutes — or more than 5½ hours.
The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.
America spends about as much on prescription drugs as all the revenues of the three big car makers combined. Tracking where the money goes is hard. PolitiFact has some charts to help.
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Lack of access means that people with physical and cognitive disabilities have a heavier burden of dental disease.
Regenexx, which runs a string of clinics, says stem cell injections can save employers a lot of money, but critics say there’s no proof.
In a new poll, consumers give thumbs up to ads that display drug prices and the removal of barriers to generics, among other cost-cutting measures.
What to know about PBMs and rebates ahead of the Senate drug price hearing on — you guessed it — PBMs.
The snake struck a 9-year-old hiker at dusk on a nature trail. The outrageous bills struck her parents a few weeks later.
The main ingredient in numerous popular herbicides has been implicated by two juries in the cancers of frequent users, but major public health agencies disagree over whether it is a carcinogen. Can you use it safely in your garden? Here are some answers to questions you may have about the weed killer glyphosate.
A pilot program for frail low-income seniors provides much-needed help in dealing with “daily activities” and offers practical solutions.
Innovations to help consumers manage their health were on display at the nation’s largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
© 2026 KFF